SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as investors aggressively position ahead of its earnings report, with community sentiment split between high expectations for a major hyperscaler contract and fears of a sell-off if the news fails to materialize. Traders are closely monitoring heavy options activity and sector-wide momentum in AI infrastructure, with many debating whether to hold through potential volatility or lock in profits from the stock's recent gains.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is experiencing intense volatility as investors speculate on a potential short squeeze and a rumored partnership with OpenAI ahead of earnings. Community sentiment remains deeply polarized, with many traders frustrated by consistent intraday sell-offs while others aggressively defend their positions based on the CEO's recent large-scale share purchases.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing intense community speculation as investors position themselves ahead of upcoming earnings, with many anticipating that a shift toward improved unit economics and strategic acquisitions will trigger a significant breakout. Discussion is dominated by bullish sentiment regarding the company's long-term path to profitability and potential for a short squeeze, while traders weigh the impact of shifting mortgage dynamics and recent operational updates.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is experiencing intense community focus ahead of its quarterly earnings release, with investors closely watching for updates on its Neutron rocket program, defense contract conversions, and revenue growth. Sentiment remains bullish, as market participants look past recent volatility, citing the company's expanding backlog and position as a key strategic partner in the growing space defense and satellite infrastructure sectors.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing a significant surge in social media activity as investors position themselves ahead of the upcoming earnings release, debating whether the stock will trigger a major short squeeze given its high short interest and institutional accumulation. The community remains sharply divided, with bulls pointing to strong AI growth narratives and potential partnerships, while bears continue to raise concerns regarding the company's path to profitability and recent valuation run-up.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is experiencing extreme volatility as investors weigh massive revenue growth and hyperscaler tailwinds against concerns over heavy debt, rising capital expenditures, and significant insider selling ahead of the earnings report. The community remains sharply divided, with bulls betting on a breakout fueled by AI demand, while bears anticipate a post-earnings sell-off due to the company's historical volatility and high burn rate.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics is facing extreme market volatility as investors weigh the significant risk of a negative regulatory outcome against the potential for an FDA approval catalyst. The community is heavily focused on the company's precarious cash position and the possibility of dilutive financing, with many debating whether the stock is a high-risk squeeze opportunity or headed for further downside.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is currently the focus of investor attention as it faces high-stakes earnings after a round of workforce reductions and ongoing debate surrounding the Clarity Act. Market participants are actively weighing concerns about the company's cost structure and competitive positioning against bullish sentiment regarding institutional adoption and its evolving role in financial infrastructure.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is experiencing extreme volatility and a sharp sell-off following quarterly earnings that investors are viewing as a 'sell the news' event despite reported growth. The community is actively debating whether the stock is a deep-value buying opportunity or if the current momentum suggests a continued slide, with many traders questioning why the market reaction has been so severe given the company's raised guidance.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors weigh potential impacts from the emerging prediction market sector and upcoming first-quarter earnings, leading to intense community debate over long-term growth prospects. Discussions are dominated by speculation on whether these new markets will cannibalize traditional sports betting revenue or serve as an additive growth driver for the platform.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Supernus Pharmaceuticals (SUPN) Beats Q1 Earnings and Revenue Estimates

Supernus (SUPN) delivered earnings and revenue surprises of +110.71% and +10.22%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Consensus Rating of "Hold" from Brokerages

Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) have been given a consensus rating of "Hold" by the nine ratings firms that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and tw...

AMPH vs. RDY: Which Stock Should Value Investors Buy Now?

AMPH vs. RDY: Which Stock Is the Better Value Option?

Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?

Amphastar (AMPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Amphastar Pharmaceuticals (AMPH) to Release Earnings on Wednesday

Amphastar Pharmaceuticals (NASDAQ:AMPH) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-amphastar-pharmaceuticals-inc-stock...

Boston Trust Walden Corp Reduces Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH

Boston Trust Walden Corp lessened its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 7.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,087,266 shares...

Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Down 7.4% - Time to Sell?

Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Down 7.4% - Should You Sell...

Amphastar Pharmaceuticals (NASDAQ:AMPH) Earns Hold Rating from Jefferies Financial Group

Jefferies Financial Group restated a "hold" rating and set a $22.00 price objective on shares of Amphastar Pharmaceuticals in a research report on Tuesday...

Amphastar Pharmaceuticals Highlights Baqsimi Milestones, Primatene Growth at Needham Conference

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives outlined growth drivers, competitive pressures, and pipeline priorities during a fireside chat at Needham & Company's 25th Annual Healthcare Conference. The discussion featured CFO Bill Peters, Senior VP of Corporate Communications Dan Dischner...

Amphastar Pharmaceuticals Inc

AMPH  Earnings Call

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

AMPH
Amphastar Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest AMPH News

AMPHAmphastar Pharmaceuticals Inc